Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model. [electronic resource]
Producer: 20161213Description: 191 p. digitalISSN:- 1471-2407
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Antineoplastic Agents -- pharmacology
- Breast Neoplasms -- diagnosis
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Dinoprostone -- metabolism
- Disease Models, Animal
- Endothelial Cells -- drug effects
- Female
- Humans
- Magnetic Resonance Imaging
- Mice
- Neoplasms, Basal Cell -- drug therapy
- Neovascularization, Pathologic -- drug therapy
- Phospholipase A2 Inhibitors -- pharmacology
- Phospholipases A2, Cytosolic -- metabolism
- Triple Negative Breast Neoplasms -- diagnosis
- Tumor Burden -- drug effects
- X-Ray Microtomography
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.